Cancer Pharma Industry

The cancer drugs market is driven by the growing prevalence of various types of cancer, increasing demand of biological and targeted drug therapies, continuous patent expiry of key cancer drugs and the rising impact of biosimilars. However, the high cost of drug development, the threat of failure and the adverse effects of cancer drug therapy, particularly chemotherapy, hinders the market growth. Advancement of cancer drug research owing to biological/targeted therapies and personalized medicines hold promising opportunities for pharmaceutical, bio-pharmaceutical and biotechnology companies engaged in developing cancer drugs.

    Related Conference of Cancer Pharma Industry

    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    August 10-11, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    September 07-08, 2026

    26th World Congress on Cancer and Diagnostics

    Paris, France
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    November 24-25, 2026

    6th International Conference on Oncology and Cancer

    Paris, France
    December 08-09, 2026

    27th World Congress on Cancer Summit

    Paris, France
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France

    Cancer Pharma Industry Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in